A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT07035041 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

UC - Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis

Interventions

DRUG: D-2570
DRUG: Placebo

Sponsor

InventisBio Co., Ltd